Skip to main content

TELA Bio, Inc S-3, filed Nov 10, 2026

TELA Bio, Inc. (TELA)

TELA Bio, Inc. plans to offer up to $150,000,000 of common stock, preferred stock, debt securities, warrants, units and subscription rights. The replacement shelf also covers $90,942,963.70 of unsold securities previously registered before the November 20, 2026 expiration. AI summary

S-3 2026-11-10
View Original
Added on November 10, 2026